When: 8th and 9th of March 2025, 8:45 am - 17:00 pm
Where: 50 George Square, Edinburgh EH8 9JU, UK
Professor Peter Hutchinson, is a distinguished neurosurgeon and Professor of Neurosurgery at the University of Cambridge. He serves as Honorary Consultant Neurosurgeon at Addenbrooke’s Hospital , Director of Clinical Research at the Royal College of Surgeons, and President of the Society of British Neurological Surgeons.
A global leader in traumatic brain injury (TBI) research, his work spans from pre-hospital care to neurointensive treatments. He has pionered innovative tools for TBI management and led major international studies, including the RESCUE trials on decompressive crainiectomy.
Professor Hutchinson’s contributions have earned him prestigous awards like the Olivecrona and Vihelm Magnus Prizes, and he was elected Fellow of the Academy of Medical Sciences in 2018. With over 750 publications and 25 million pounds in research funding.
Professor Tara Spires-Jones studies neurodegeneration in Alzhimer’s disease, focusing on synaptic dysfunction and ways to reverse it. Her work has shown that amyloid beta and tau proteins drive synaptic degeneration, and reducing these proteins can reverse disease features in models. Her team has also found that tau spreads through synapses and identified resilience factors to cognitive decline in aging. With over 100 papers cited 20,000+ times, she has advanced imaging techniques to study protein buildup in human brain disease.
Beyond research, Professor Spires-Jones advocates for public science engagement, rigor in neuroscience, and supporting early-career scientists. She is president of the British Neuroscience Association, and founding editor of Brain Communications. Previously, she led Alzhimer’s research at Massachusetts General Hospital and Harvard Medical School, and holds degrees from Oxford and the University of Texas at Austin.
Professor Siddharthan Chandran is Director of the UK Dementia Research Institute, and an internationally leading expert in neurodegenerative diseases. Prof Chandran is a practising neurologist and scientist working at the forefront of the emerging discipline of Regenerative Neurology, renowned for his work in motor neuron disease (MND) and MS that combines laboratory and clinical research with a particular focus on human / patient stem cells for his discovery science research. Alongside his UK DRI research, Prof Chandran is Director of the Euan MacDonald Centre for Motor Neuron Disease Research and the Anne Rowling Regenerative Neurology Clinic at the University of Edinburgh. He is also a Fellow of the Royal Society of Edinburgh and the Academy of Medical Science.
Professor Paul is Reader and Honorary Consultant Neurosurgeon at the University of Edinburgh and NHS Lothian.
Professor Paul's research spans the laboratory and the clinic, combining molecular, epidemiology and clinical investigation to guide rationale innovation to improve patient care. He applies this strategy to improving diagnosis, treatment and outcomes for people with brain tumours, and traumatic brain or spinal injuries. As founder of University of Edinburgh spin-out, eoSurgical Ltd, he has also led innovation in surgical simulation training around the world.
In the laboratory he probes mechanistic hypotheses generated by using large scale clinical data to drive discovery science. He collaborates on bringing innovative technologies to the clinic, developing the clinical and scientific evidence for adoption in routine care, such as the Clinspec Dx spectroscopic liquid biopsy test that can both stratify tumour risk in a symptomatic patient population, and predict tumour phenotype.
He is part of the CRUK Adult Brain Tumour Centre of Excellence, based on Edinburgh.
Dr. Seward Rutkove, MD serves as the Principal Investigator in a National Institutes of Health funded study aimed at developing a novel technology based on measurements of impedance parameters of muscle. Dr. Rutkove serves as Associate Professor of Neurology at Harvard Medical School and Director of the Neuromuscular Division in the Department of Neurology at Beth Israel Deaconess Medical Center in Boston. He served as Member of Neurology Advisory Board for NeuroMetrix Inc. He is board certified in neurology, clinical neurophysiology, and electrodiagnostic medicine. He is the author of more than 30 articles in the field of neurophysiologic testing and neuromuscular disease and is an active member of the American Academy of Neurology and American Association of Electrodiagnostic Medicine. His special interests include the effect of temperature on neurophysiologic parameters and its potential role in the symptoms and pathogenesis of neuropathy.
With a career spanning decades, Mr. Henry Marsh has transformed the field of neurosurgery through pioneering techniques and an unwavering commitment to patient care. His groundbreaking work has been spotlighted in two acclaimed BBC documentaries—Your Life in Their Hands (2003) and the Emmy-winning The English Surgeon (2009)—offering a profound glimpse into the challenges, triumphs, and human stories behind the operating room.
Beyond the surgical theater, Mr. Marsh is an acclaimed author of three bestselling memoirs: Do No Harm, Admissions, and And Finally. These works provide an unflinching look into the ethical complexities, personal struggles, and emotional depth of life in neurosurgery, inspiring countless readers, medical professionals, and students worldwide.
Dr Richard Davenport qualified from Nottingham in 1987, completed general medical training in Stoke-on-Trent, moved to Edinburgh in 1992, and after his DM thesis in stroke spent a year in Australia, before returning to Edinburgh as one of the last Senior Registrars. Dr Davenport was appointed consultant in 1999. Whilst very much a general neurologist, he undertakes NHS first seizure, movement disorder and MND clinics.
Richard was elected to the Association of British Neurologists Council in 2009, appointed Chair of the Training and Education committee in 2010, demitting in 2016. In 2019 he was appointed ABN Meetings secretary and in April 2021 elected President Elect of the ABN, beginning his term of office in 2023. He was Chair of National Advisory Committee for Neurological Conditions (Scotland) for 3 years from 2017 and Specialty Advisor to Chief Medical Officer (Neurology) 2017-2023.
More announcements to come!!
More announcements to come!!